
Intraoperative Fluorescence Imaging Market Report 2026
Global Outlook – By Component (Products, Services), By Technology (Near Infrared Fluorescence Imaging, Visible Light Fluorescence Imaging, Targeted Fluorescence Imaging, Non Targeted Fluorescence Imaging), By Modality (Open Surgery Imaging Systems, Minimally Invasive Or Laparoscopic Imaging Systems, Robotic Assisted Imaging Systems), By Application (Oncology Surgery, Cardiovascular Surgery, Neurosurgery, Reconstructive Surgery, Gastrointestinal Surgery, Urology Surgery, Post Stroke Rehabilitation Procedures), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research And Academic Institutes) – Market Size, Trends, Strategies, and Forecast to 2030
Intraoperative Fluorescence Imaging Market Overview
• Intraoperative Fluorescence Imaging market size has reached to $0.68 billion in 2025 • Expected to grow to $1.31 billion in 2030 at a compound annual growth rate (CAGR) of 14.3% • Growth Driver: Rising Preference For Minimally Invasive Procedures Driving The Market Growth Due To Reducing Patient Trauma And Faster Postoperative Recovery Outcomes • Market Trend: Advancements In Real-Time Surgical Imaging For Enhanced Intraoperative Precision • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Intraoperative Fluorescence Imaging Market?
Intraoperative fluorescence imaging is a real-time surgical imaging method that uses fluorescent dyes and specialized cameras to visualize internal structures such as blood vessels, tissues, and tumors during an operation. It enhances the surgeon’s ability to clearly distinguish healthy from diseased tissue, assess blood flow, and improve precision in procedures such as cancer surgery and reconstructive surgery, ultimately supporting safer and more accurate surgical outcomes. The main components of intraoperative fluorescence imaging include products and services. Products refer to specialized imaging systems and agents used during surgery to provide real-time visualization of tissues, blood flow, and tumor margins. These technologies are based on modalities including near infrared fluorescence imaging, visible light fluorescence imaging, targeted fluorescence imaging, and non targeted fluorescence imaging and are utilized across system types such as open surgery imaging systems, minimally invasive or laparoscopic imaging systems, and robotic assisted imaging systems. The various applications involved are oncology surgery, cardiovascular surgery, neurosurgery, reconstructive surgery, gastrointestinal surgery, urology surgery, and post stroke rehabilitation procedures, and they are used by several end users such as hospitals, ambulatory surgical centers, specialty clinics, and research and academic institutes.
What Is The Intraoperative Fluorescence Imaging Market Size and Share 2026?
The intraoperative fluorescence imaging market size has grown rapidly in recent years. It will grow from $0.68 billion in 2025 to $0.77 billion in 2026 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to limited real time surgical visualization tools, high intraoperative complication rates, increasing adoption of minimally invasive surgery, early use of dye based angiography techniques, growing demand for precision oncology surgery.What Is The Intraoperative Fluorescence Imaging Market Growth Forecast?
The intraoperative fluorescence imaging market size is expected to see rapid growth in the next few years. It will grow to $1.31 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to expansion of AI driven surgical imaging systems, rising demand for precision and personalized surgery, increasing adoption of robotic assisted operations, advancements in fluorescence contrast agent development, growing integration of real time imaging in hybrid operating rooms. Major trends in the forecast period include AI assisted surgical fluorescence interpretation, real time intraoperative image guided surgery adoption, advanced tumor margin detection accuracy enhancement, integration of robotic assisted fluorescence guided procedures, development of next generation near infrared contrast agents.Global Intraoperative Fluorescence Imaging Market Segmentation
1) By Component: Products, Services 2) By Technology: Near Infrared Fluorescence Imaging, Visible Light Fluorescence Imaging, Targeted Fluorescence Imaging, Non Targeted Fluorescence Imaging 3) By Modality: Open Surgery Imaging Systems, Minimally Invasive Or Laparoscopic Imaging Systems, Robotic Assisted Imaging Systems 4) By Application: Oncology Surgery, Cardiovascular Surgery, Neurosurgery, Reconstructive Surgery, Gastrointestinal Surgery, Urology Surgery, Post Stroke Rehabilitation Procedures 5) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research And Academic Institutes Subsegments: 1) By Products: Fluorescence Imaging Systems, Near Infrared Fluorescence Systems, Imaging Cameras And Detectors, Imaging Software 2) By Services: Installation And System Integration Services, Maintenance And Repair Services, Calibration And Performance Testing Services, Training And Surgical Support ServicesWhat Is The Driver Of The Intraoperative Fluorescence Imaging Market?
The growing preference for minimally invasive procedures is expected to propel the growth of the intraoperative fluorescence imaging market going forward. Minimally invasive procedures are medical techniques that use small incisions or natural openings with specialized instruments to reduce tissue damage, pain, and recovery time compared to open surgery. Minimally invasive procedures are increasing mainly as they enable faster patient recovery with less pain and shorter hospital stays due to reduced tissue damage. Intraoperative fluorescence imaging helps with minimally invasive procedures by providing real-time visual guidance of blood flow, tissue perfusion, and critical structures using fluorescent dyes, allowing surgeons to operate through small incisions with greater precision, reduced risk of injury, and improved surgical outcomes. For instance, in March 2023, according to the British Association of Aesthetic Plastic Surgeons, a UK-based surgical organization, 31,057 cosmetic surgeries took place in 2022 in the UK, marking a notable 102% increase from the previous year. Therefore, the growing preference for minimally invasive procedures is driving the growth of the intraoperative fluorescence imaging industry.Key Players In The Global Intraoperative Fluorescence Imaging Market
Major companies operating in the intraoperative fluorescence imaging market are Medtronic plc, Stryker Corporation, Intuitive Surgical Inc., Olympus Corporation, Carl Zeiss Meditec AG, KARL STORZ SE & Co. KG, Shimadzu Corporation, Hamamatsu Photonics K.K., Leica Microsystems, Richard Wolf GmbH, SCHÖLLY FIBEROPTIC GMBH, Guerbet, Diagnostic Green GmbH, LI-COR Biosciences, Activ Surgical Inc., OnLume Inc., Curadel Pharma Inc., SurgiMab SAS, FluoGuideGlobal Intraoperative Fluorescence Imaging Market Trends and Insights
Major companies operating in the intraoperative fluorescence imaging market are focusing on developing innovative solutions such as the near-infrared (NIR) fluorescence imaging module to enhance real-time tissue visualization, improve surgical precision, and support better intraoperative decision-making. A near-infrared (NIR) fluorescence imaging module is a surgical imaging technology that uses near-infrared light and fluorescent dyes to provide real-time visualization of tissues and blood flow during surgery. For instance, in March 2024, Synaptive Medical Inc., a Canada-based medical device company, received FDA 510(k) clearance for Modus IR, its near-infrared fluorescence module integrated with the Modus X robotic exoscope. The solution enables surgeons to visualize indocyanine green fluorescence and blood vessels in real time during microsurgical procedures, enhancing intraoperative imaging and surgical precision.What Are Latest Mergers And Acquisitions In The Intraoperative Fluorescence Imaging Market?
In November 2025, FluoGuide A/S, a Denmark-based clinical-stage biotech company, partnered with Carl Zeiss AG to develop FG001 for tumor imaging and surgical margin assessment in head and neck cancer surgery. With this partnership, companies aim to combine FG001 and ZEISS surgical imaging systems to improve real-time tumor visualization and surgical margin assessment in cancer surgery. Carl Zeiss AG is a Germany-based technology company that offers intraoperative fluorescence imaging solutions.Regional Outlook
North America was the largest region in the intraoperative fluorescence imaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Intraoperative Fluorescence Imaging Market?
The intraoperative fluorescence imaging market consists of revenues earned by entities by providing services such as tissue perfusion assessment, tumor margin visualization, and sentinel lymph node mapping. The market value includes the value of related goods sold by the service provider or included within the service offering. The intraoperative fluorescence imaging market also includes sales of fluorescence-guided surgery systems, intraoperative imaging cameras, real-time surgical navigation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Intraoperative Fluorescence Imaging Market Report 2026?
The intraoperative fluorescence imaging market research report is one of a series of new reports from The Business Research Company that provides intraoperative fluorescence imaging market statistics, including intraoperative fluorescence imaging industry global market size, regional shares, competitors with a intraoperative fluorescence imaging market share, detailed intraoperative fluorescence imaging market segments, market trends and opportunities, and any further data you may need to thrive in the intraoperative fluorescence imaging industry. This intraoperative fluorescence imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.Intraoperative Fluorescence Imaging Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $0.77 billion |
| Revenue Forecast In 2030 | $1.31 billion |
| Growth Rate | CAGR of 14.3% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Component, Technology, Modality, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the intraoperative fluorescence imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Medtronic plc, Stryker Corporation, Intuitive Surgical Inc., Olympus Corporation, Carl Zeiss Meditec AG, KARL STORZ SE & Co. KG, Shimadzu Corporation, Hamamatsu Photonics K.K., Leica Microsystems, Richard Wolf GmbH, SCHÖLLY FIBEROPTIC GMBH, Guerbet, Diagnostic Green GmbH, LI-COR Biosciences, Activ Surgical Inc., OnLume Inc., Curadel Pharma Inc., SurgiMab SAS, FluoGuide |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
